Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure

NCT02501811 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Cardiomyopathy

Interventions

BIOLOGICAL: Mesenchymal Stem Cells (MSC)
BIOLOGICAL: c-kit+ cells
BIOLOGICAL: Placebo (Plasmalyte A)

Sponsor

The University of Texas Health Science Center, Houston

Collaborators

[object Object]